TGFB1 and neoplasm: To investigate whether CCL18 mediates the activation of fibroblasts in the tumor stroma, NBFs isolated from reduction mammaplasty samples were treated with recombinant CCL18 and TGF-β, which is typically used as a positive control for fibroblast activation [31, 32].